Tsuguo Ogasawara
Director/Board Member at CARNA BIOSCIENCES, INC.
Network origin in Tsuguo Ogasawara first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tsuguo Ogasawara via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AIR WATER INC. | Chemicals: Specialty | Director/Board Member | |
| TOYO GOSEI CO.,LTD. | Chemicals: Specialty | Director/Board Member | |
| MEDINET CO., LTD. | Biotechnology | Director/Board Member | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Kyoto University | College/University | Doctorate Degree | |
| Tokyo Institute of Technology | College/University | Graduate Degree | |
| Japan Health Sciences Foundation | Chairman | ||
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member President Corporate Officer/Principal | |
ProbeX, Inc.
 ProbeX, Inc. Medical/Nursing ServicesHealth Services Part of Carna Biosciences, Inc., ProbeX, Inc. is a Japanese company that develops, manufactures, and distributes molecular imaging probe reagents. The company is based in Tokyo, Japan. ProbeX was acquired by Carna Biosciences, Inc. from Life Science Management, Inc. on October 01, 2013 for $2.82 million. | Medical/Nursing Services | President | |
| KRINGLE PHARMA, INC. | Biotechnology | Director/Board Member | |
Institute of Accelerator Analysis, Ltd.
 Institute of Accelerator Analysis, Ltd. Miscellaneous Commercial ServicesCommercial Services Institute of Accelerator Analysis Ltd. provides accelerator mass spectrometry analysis services. Its specializes in pharmacokinetic analysis and radiocarbon dating. The firm also offers in-vitro studies in the early stages of drug development as well as drug concentration measurement in biological samples. The company was founded by Takao Mutsui on March 29, 1999 and is headquartered in Kawasaki, Japan. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistics
International
| Japan | 12 |
| United States | 2 |
Sectoral
| Health Technology | 4 |
| Process Industries | 3 |
| Consumer Services | 3 |
| Health Services | 3 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 21 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 5 |
| President | 5 |
| Chief Administrative Officer | 3 |
Most connected contacts
- Stock Market
- Insiders
- Tsuguo Ogasawara
- Company connections
